336 related articles for article (PubMed ID: 23974296)
1. Stepwise oligomerization of murine amylin and assembly of amyloid fibrils.
Palmieri LC; Melo-Ferreira B; Braga CA; Fontes GN; Mattos LJ; Lima LM
Biophys Chem; 2013; 180-181():135-44. PubMed ID: 23974296
[TBL] [Abstract][Full Text] [Related]
2. Rapid assessment of human amylin aggregation and its inhibition by copper(II) ions by laser ablation electrospray ionization mass spectrometry with ion mobility separation.
Li H; Ha E; Donaldson RP; Jeremic AM; Vertes A
Anal Chem; 2015 Oct; 87(19):9829-9837. PubMed ID: 26352401
[TBL] [Abstract][Full Text] [Related]
3. Role of mass spectrometry in the study of interactions between amylin and metal ions.
Moracci L; Crotti S; Traldi P; Agostini M; Cosma C; Lapolla A
Mass Spectrom Rev; 2023 May; 42(3):984-1007. PubMed ID: 34558100
[TBL] [Abstract][Full Text] [Related]
4. Amyloidogenesis of the amylin analogue pramlintide.
da Silva DC; Fontes GN; Erthal LC; Lima LM
Biophys Chem; 2016 Dec; 219():1-8. PubMed ID: 27665170
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the assembly and amyloid aggregation of murine amylin by zinc.
Erthal LC; Marques AF; Almeida FC; Melo GL; Carvalho CM; Palmieri LC; Cabral KM; Fontes GN; Lima LM
Biophys Chem; 2016 Nov; 218():58-70. PubMed ID: 27693831
[TBL] [Abstract][Full Text] [Related]
6. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties.
Tenidis K; Waldner M; Bernhagen J; Fischle W; Bergmann M; Weber M; Merkle ML; Voelter W; Brunner H; Kapurniotu A
J Mol Biol; 2000 Jan; 295(4):1055-71. PubMed ID: 10656810
[TBL] [Abstract][Full Text] [Related]
7. Structural and energetic insight into the cross-seeding amyloid assemblies of human IAPP and rat IAPP.
Zhang M; Hu R; Liang G; Chang Y; Sun Y; Peng Z; Zheng J
J Phys Chem B; 2014 Jun; 118(25):7026-36. PubMed ID: 24892388
[TBL] [Abstract][Full Text] [Related]
8. Fibril formation and toxicity of the non-amyloidogenic rat amylin peptide.
Milton NG; Harris JR
Micron; 2013 Jan; 44():246-53. PubMed ID: 22854213
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous triangular structures of human islet amyloid polypeptide (amylin) with internal hydrophobic cavity and external wrapping morphology reveal the polymorphic nature of amyloid fibrils.
Zhao J; Yu X; Liang G; Zheng J
Biomacromolecules; 2011 May; 12(5):1781-94. PubMed ID: 21428404
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.
Jaikaran ET; Nilsson MR; Clark A
Biochem J; 2004 Feb; 377(Pt 3):709-16. PubMed ID: 14565847
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human islet amyloid polypeptide or amylin aggregation by two manganese-salen derivatives.
Bahramikia S; Yazdanparast R
Eur J Pharmacol; 2013 May; 707(1-3):17-25. PubMed ID: 23528352
[TBL] [Abstract][Full Text] [Related]
12. Nanoscale Heterogeneity of the Molecular Structure of Individual hIAPP Amyloid Fibrils Revealed with Tip-Enhanced Raman Spectroscopy.
vandenAkker CC; Deckert-Gaudig T; Schleeger M; Velikov KP; Deckert V; Bonn M; Koenderink GH
Small; 2015 Sep; 11(33):4131-9. PubMed ID: 25952953
[TBL] [Abstract][Full Text] [Related]
13. pH dependence of amylin fibrillization.
Jha S; Snell JM; Sheftic SR; Patil SM; Daniels SB; Kolling FW; Alexandrescu AT
Biochemistry; 2014 Jan; 53(2):300-10. PubMed ID: 24377660
[TBL] [Abstract][Full Text] [Related]
14. The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells.
Konarkowska B; Aitken JF; Kistler J; Zhang S; Cooper GJ
FEBS J; 2006 Aug; 273(15):3614-24. PubMed ID: 16884500
[TBL] [Abstract][Full Text] [Related]
15. Full-length rat amylin forms fibrils following substitution of single residues from human amylin.
Green J; Goldsbury C; Mini T; Sunderji S; Frey P; Kistler J; Cooper G; Aebi U
J Mol Biol; 2003 Feb; 326(4):1147-56. PubMed ID: 12589759
[TBL] [Abstract][Full Text] [Related]
16. Nano-scale imaging and dynamics of amylin-membrane interactions and its implication in type II diabetes mellitus.
Cho WJ; Jena BP; Jeremic AM
Methods Cell Biol; 2008; 90():267-86. PubMed ID: 19195555
[TBL] [Abstract][Full Text] [Related]
17. Human Amylin: From Pathology to Physiology and Pharmacology.
Ling W; Huang YM; Qiao YC; Zhang XX; Zhao HL
Curr Protein Pept Sci; 2019; 20(9):944-957. PubMed ID: 30919775
[TBL] [Abstract][Full Text] [Related]
18. Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin.
Nilsson MR; Raleigh DP
J Mol Biol; 1999 Dec; 294(5):1375-85. PubMed ID: 10600392
[TBL] [Abstract][Full Text] [Related]
19. The role of protein sequence and amino acid composition in amyloid formation: scrambling and backward reading of IAPP amyloid fibrils.
Sabaté R; Espargaró A; de Groot NS; Valle-Delgado JJ; Fernàndez-Busquets X; Ventura S
J Mol Biol; 2010 Nov; 404(2):337-52. PubMed ID: 20887731
[TBL] [Abstract][Full Text] [Related]
20. Ion mobility spectrometry-mass spectrometry defines the oligomeric intermediates in amylin amyloid formation and the mode of action of inhibitors.
Young LM; Cao P; Raleigh DP; Ashcroft AE; Radford SE
J Am Chem Soc; 2014 Jan; 136(2):660-70. PubMed ID: 24372466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
